Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:
Ana Nikolic × Clear Filters

1 results found

Dissecting PRC2 dysfunction in IDH-mutant oligodendroglioma

A type of brain tumour called IDH-mutant glioma is the most common brain tumour in young adults aged 20 to 40. While patients can survive for over a decade, these tumours are incurable, and require repeated surgeries and aggressive treatments. These tumours come in two forms: astrocytomas and oligodendrogliomas. Oligodendrogliomas respond better to chemotherapy and patients live longer, but we do not fully understand why.
Project ongoing See Project & Researchers
Grant type
Capacity building grants
Area of Research
Cancer
Competition
Future Leaders in Canadian Brain Research
Province
Alberta
Start Date
2026